Literature DB >> 5502446

Pediatric cholera.

I C Verma.   

Abstract

Mesh：

Substances：

Year:  1970        PMID： 5502446     DOI： 10.1007/bf02813171

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN： 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  8 in total

1.  EXPERIMENTAL CHOLERA PRODUCED BY TOXIN PREPARED BY ULTRASONIC DISINTEGRATION OF VIBRIO COMMA.

Authors:  N B Oza; N K Dutta
Journal:  J Bacteriol       Date:  1963-02       Impact factor: 3.490

2.  Electrolyte replacement in paediatric cholera.

Authors:  L S Griffith; J W Fresh; R H Watten; M P Villaroman
Journal:  Lancet       Date:  1967-06-03       Impact factor: 79.321

3.  Furazolidone in the treatment of cholera.

Authors:  R N Chaudhuri; K N Neogy; S N Sanyal; R K Gupta; P Manji
Journal:  Lancet       Date:  1968-02-17       Impact factor: 79.321

4.  Report of the 1966-67 cholera vaccine field trial in rural East Pakistan. I. Study design and results of the first year of observation.

Authors:  W H Mosley; W M McCormack; M Fahimuddin; K M Aziz; A S Rahman; A K Chowdhury; A R Martin; J C Feeley; R A Phillips
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

5.  Experimental canine cholera. 3. Serologic studies and re-challenge experiments.

Authors:  R B Sack; C C Carpenter
Journal:  J Infect Dis       Date:  1969-02       Impact factor: 5.226

6.  The relationship of superior mesenteric artery blood flow to gut electrolyte loss in experimental cholera.

Authors:  C C Carpenter; W B Greenough; R B Sack
Journal:  J Infect Dis       Date:  1969-02       Impact factor: 5.226

7.  Water and electrolyte losses due to cholera in infants and small children: a recovery balance study.

Authors:  D Mahalanabis; C K Wallace; R J Kallen; A Mondal; N F Pierce
Journal:  Pediatrics       Date:  1970-03       Impact factor: 7.124

8.  Antibiotic therapy of cholera in children.

Authors:  J Lindenbaum; W B Greenough; M R Islam
Journal:  Bull World Health Organ       Date:  1967       Impact factor: 9.408
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.